Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

641 public trials 136 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +20 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 62 locations
View Trial Details
Recruiting

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

NCT07524855

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

NCT06072612

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Diseases, +12 more
Locations
  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic Phoenix, Arizona, United States
  • University of Arizona-Cancer Center Tucson, Arizona, United States
  • Los Angeles cancer Network_Anaheim Anaheim, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 79 locations
View Trial Details
Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

NCT07085767

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Clinical Trial Site Hot Springs, Arkansas, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Alamitos, California, United States
View all 181 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

NCT03424005

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Rocky Mountain Cancer Center - Longmont Longmont, Colorado, United States
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Hospital of Traditional Chinese Medicine) Lanzhou, Gansu, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Wenzhou Medical University Affiliated Second Hospital Wenzhou, Zhejiang, China
View all 29 locations
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details

Related conditions